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Background: Bcl-3 is an essential negative regulator of cytokine expression.
Results: A mutation in NF-B p50 that prevents interaction with Bcl-3 abrogates Bcl-3 inhibition of gene expression.
Conclusion: The inhibition of cytokine expression by Bcl-3 requires interaction with NF-B p50.
Significance: NF-B p50 is the key target of Bcl-3 anti-inflammatory activity.
B cell leukemia 3 (Bcl-3) is an essential negative regulator of
NF-B during Toll-like receptor and TNF receptor signaling.
Bcl-3 also interacts with a number of transcriptional regulators,
including homodimers of the NF-B p50 subunit. Deletion of
Bcl-3 results in increased NF-B p50 ubiquitination and protea-
somal degradation and increased inflammatory gene expres-
sion. We employed immobilized peptide array technology to
define a region of p50 required for the formation of a Bcl-3p50
homodimer immunosuppressor complex. Our data demon-
strate that amino acids 359 –361 and 363 of p50 are critical for
interaction with Bcl-3 and essential for Bcl-3-mediated inhibi-
tion of inflammatory gene expression. Bcl-3 is unable to interact
with p50 when these amino acids are mutated, rendering it inca-
pable of inhibiting the transcriptional activity of NF-B. Bcl-3
interaction-defective p50 is hyperubiquitinated and has a signif-
icantly reduced half-life relative to wild-type p50. Nfkb1/ cells
reconstituted with mutated p50 precursor p105 are hyperre-
sponsive to TNF stimulation relative to wild-type p105, as
measured by inflammatory gene expression. Mutant p105 reca-
pitulates a Bcl3/ phenotype. This study demonstrates that
interaction with p50 is necessary and sufficient for the anti-in-
flammatory properties of Bcl-3 and further highlights the
importance of p50 homodimer stability in the control of NF-B
target gene expression.
The members of the NF-B family of transcription factors
are essential regulators of the immune response and control the
expression of hundreds of immunomodulatory genes. This
transcription factor family is encoded by five genes, resulting in
five NF subunits (p65 (RelA), c-Rel, RelB, p50, and p52) that,
through the formation of hetero- and homodimers, can poten-
tially generate 15 distinct complexes (1). All subunits of NF-B
share significant sequence homology and are characterized by
the Rel homology domain (RHD)2, which is essential for
dimerization and DNA binding. Genetic studies in mice have
demonstrated that individual NF-B subunits carry out specific
biological roles (2), which may be due to distinct subunit spe-
cific cofactors (3) as well as dimer-specific affinities for variable
DNA binding sequences (4).
The NF-B p50 and p52 subunits share a number of proper-
ties that distinguish them from other NF-B subunits. Firstly,
they are both generated from the limited proteolytic processing
of a precursor: p105 in the case of p50 and p100 in the case of
p52. Secondly, p50 and p52 do not contain a transactivation
domain and, when complexed as homodimers, they do not pos-
sess intrinsic transactivational activity (1). In this regard, p50
homodimers are generally considered as repressors of NF-B
transcription. Interestingly, p50 homodimers have also recently
been identified as negative regulators of interferon regulatory
factor (IRF)-mediated transcription by binding to interferon-
responsive elements in interferon-inducible gene promoters,
which act as an NF-B half-site (5). A significant number of p50
homodimers are present in the nuclei of unstimulated cells,
which indicates that p50 plays a critical role in regulating the
basal as well as inducible transcription of target genes (5).
In resting cells, NF-B is sequestered in the cytoplasm
through association with members of the IB protein family,
which include IB, IB, IB, as well as p105 and p100. Acti-
vating stimuli trigger IB kinase (IKK)-mediated phosphoryla-
tion of cytoplasmic IB, leading to its ubiquitination and sub-
sequent proteasomal degradation, thereby allowing NF-B to
translocate to the nucleus. There are also a number of atypical
IB proteins, which include Bcl-3, IB, and IBNS, which
reside predominantly in the nucleus and are not degraded fol-
lowing activation of the IKK complex (6). Bcl-3 is perhaps the
best studied of the atypical IB proteins. It was originally iden-
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tified at the breakpoint junction t(14;19) in B cell chronic lym-
phocytic leukemia and is classified as an IB family member by
virtue of its seven ankyrin repeat domains that mediate selec-
tive interaction with homodimers of NF-B p50 and p52 (7).
Bcl-3 has also been reported to interact with the AP-1 tran-
scription factors c-Jun and c-fos (8); STAT1 (9); peroxisome
proliferator-activated receptor (PPAR) (10); CREB-binding
protein/p300 (8); HDAC-1, -3, and -5 (11); steroid receptor
coactivator 1 (8); TORC3 (12); and the retinoic X receptor (13).
Bcl-3 has also been reported to interact with the Src-related
kinases Fyn (14) and Lck (15) as well as insulin receptor sub-
strate 3 (IRS3) (16) and Bag-1 (17). Previous data suggest that
Bcl-3-mediated stabilization of p50 is required for limiting
NF-B transcriptional activity. In Bcl3/ macrophages, p50
homodimers undergo increased ubiquitination and protea-
somal degradation. Bcl3/ cells and mice are hyperresponsive
to Toll-like receptor and TNF receptor stimulation, as mea-
sured by the increased transcription of genes, including TNF
and IL-6 (18). The nature of the interaction between Bcl-3 and
p50 has not been explored experimentally, and it is not clear
whether Bcl-3 interaction with p50 is essential for the inhibi-
tion of cytokine expression or whether the other binding part-
ners of Bcl-3 are also important. This information is critical for
our understanding of the regulation of NF-B activity and cyto-
kine expression by Bcl-3 and p50 homodimers.
Here we employed immobilized peptide array technology to
identify the regions of p50 essential for interaction with Bcl-3.
We identified amino acids 359 –361 and 363 of p50 as critical
residues required for the interaction of p50 homodimers with
Bcl-3. This allowed us to generate a p50 mutant that is unable to
interact with Bcl-3 but that retains normal dimerization and
DNA-binding properties. p50 homodimers that are unable to
interact with Bcl-3 undergo increased ubiquitination that is not
inhibited by overexpression of Bcl-3. Importantly, the Bcl-3
interaction-defective p50 mutant is also defective in its ability
to repress NF-B target gene expression. Overexpression of
Bcl-3 is unable to repress NF-B-mediated gene expression in
cells expressing the mutant form of p50. Our study describes
the experimental characterization of the interaction between
p50 and Bcl-3 and demonstrates, for the first time, that a direct
interaction between Bcl-3 and p50 is required for the stability of
p50 homodimers and is necessary for the anti-inflammatory
function of Bcl-3.
EXPERIMENTAL PROCEDURES
Cell Culture, Plasmids, and Transfection—HEK293T and
RAW 264.7 cells were cultured in DMEM containing 10% fetal
bovine serum, 2 mM glutamine, and 100 units/ml penicillin/
streptomycin. Transfections were performed using Turbofect
(Fermentas) or XtremeGENE HP (Roche) according to the
instructions of the manufacturer. Nfkb1/ MEFs were cul-
tured in DMEM containing 10% bovine calf serum, 2 mM glu-
tamine, and 100 units/ml penicillin/streptomycin. Transfec-
tion of MEF cells was performed using Attractene (Qiagen)
according to the instructions of the manufacturer. For stable
transfection, cells were clonally selected by growing in medium
containing 0.2 mg/ml zeocin (InvivoGen). Mammalian expres-
sion vectors for Bcl-3, p50, and p105 were generated following
PCR amplification and ligation of murine cDNAs into the
pcDNA3.1-Myc and pRK5-FLAG vectors. The Bcl-3 binding-
defective mutants were generated using the QuikChange kit
according to the instructions of the manufacturer (Stratagene).
Bcl-3 was ligated into pGEX6p1 to produce a GST-Bcl-3
expression vector. The hydrophobicity analysis of p50 was per-
formed using the Bioannotator module of the Vector NTI soft-
ware suite (Invitrogen) (19).
Bacterial Protein Expression and Purification—For purifica-
tion of GST and GST-Bcl-3, Escherichia coli BL21 CodonPlus
(Stratagene) was transformed with pGEX-6p1 or pGEX-6p1-
Bcl-3. Cells were grown to an A600 of 1.0 –2.0 at 37 °C and
induced with 1.0 mM (GST) or 0.1 mM (GST-Bcl-3) isopropyl
1-thio--D-galactopyranoside for 16 h at 20 °C. The bacteria
were pelleted; resuspended in a buffer containing 50 mM Tris
(pH 8.0), 150 mM NaCl, and 1 mM dithiothreitol; disrupted by
sonication; and centrifuged to remove debris. Recombinant
proteins were affinity-purified with GSH-agarose (Sigma) and
eluted with 10 mM glutathione (Promega) in 50 mM Tris
(pH8.5) and 150 mM NaCl.
GST Pulldown Assay—HEK293T cells were transiently
transfected with FLAG-p50WT or p50RKR. Whole cell lysates
were extracted from cells resuspended in GST lysis and binding
buffer (20 mM Tris-Cl (pH 8.0), 200 mM NaCl, 1 mM EDTA (pH
8.0), and 0.5% Nonidet P-40) supplemented with aprotinin,
pepstatin, and PMSF. Equal amounts of lysates were precleared
in 1 ml of binding buffer with 50 l of GSH-agarose for 2 h
rotating at 4 °C. GST or GST-Bcl-3 were incubated with pre-
cleared lysates and affinity-purified with 50 l of GSH-agarose
for 2 h rotating at 4 °C. Following the wash steps, pulldown
complexes were eluted from the beads with 2 SDS gel loading
buffer (100 mM Tris-Cl (pH 6.8), 4% (w/v) SDS, 0.2% (w/v) bro-
mphenol blue, 20%(w/v) glycerol, and 200 mM - mercaptoeth-
anol) and analyzed by Western blot analysis.
SPOT Synthesis of Peptides and Overlay Analysis—Peptide
libraries of p50 were generated by automatic SPOT synthesis as
described previously (20) and synthesized on continuous cellu-
lose membrane supports on Whatman 50 cellulose using Fmoc
(N-(9-flurenyl)methoxycarbonyl) chemistry with AutoSpot-
Robot ASS 222 (Intavis Bioanalytical Instruments). The inter-
action of GST and GST-Bcl3 was investigated by overlaying the
cellulose membrane with 10 g/ml of each recombinant pro-
tein overnight at 4 °C. Bound protein was detected by immuno-
blotting with anti-GST and a secondary anti-rabbit antibody
coupled with horseradish peroxidase. Specific alanine-scan-
ning substitution arrays were generated using the same synthe-
sis procedure. Bound protein was detected by immunoblotting
with anti-GST and an IR-800-conjugated anti-rabbit secondary
antibody (Pierce).
Western Blot Analysis and Immunoprecipitation—For West-
ern blot analysis, whole cell lysates were extracted from cells
suspended in radioimmune precipitation assay buffer contain-
ing 50 mM Tris-HCl (pH 7.4), 1% Nonidet P-40, 0.25% deoxy-
cholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM NaF, 1
mM Na3VO4, 2 g/ml aprotinin, 1 g/ml pepstatin, and 1 g/ml
leupeptin. Nuclear extracts were obtained using a nuclear
extract kit according to the instruction of the manufacturer
(Active Motif). Lysates were resolved on SDS-PAGE gels, trans-
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ferred to nitrocellulose membranes, and immunoblotted with
specific antibodies. Phospho- IB and IB were purchased
from Cell Signaling Technology. Anti-FLAG M2, anti--actin,
and anti-tubulin were purchased from Sigma, and anti-Bcl-3
was purchased from Active Motif. Anti-c-MYC (9E10), anti-
HDAC1, and anti-p50 (C-19) were obtained from Santa Cruz
Biotechnology. For immunoprecipitation, equal amounts of
whole cell extracts were precleared for 30 min at 4 °C with pro-
tein G-agarose beads (Millipore) and immunoprecipitated with
primary antibody overnight at 4 °C. Pellets were washed three
times in radioimmune precipitation assay buffer and resus-
pended in 2 sample buffer. Equal volumes of resuspended
immunoprecipitates were analyzed by Western blot analysis.
For ubiquitination assays, cells were incubated with 10 mM
N-ethylmaleimide for 30 s and washed in PBS/10 mM N-ethyl-
maleimide. Cells were lysed in 1% SDS, boiled for 5 min, and
sonicated. Cleared lysates were diluted (1:10) in radioimmune
precipitation assay buffer supplemented with 20 mM N-ethyl-
maleimide. Immunoprecipitation was performed as above and
analyzed by Western blot analysis using an anti-HA antibody
(Roche) to detect ubiquitinated p50 species. For endogenous
ubiquitination assays, p50 was immunoprecipitated with anti-
NF-B p50 (Enzo), and Western blots were incubated in 0.5%
glutaraldehyde/PBS (pH 7.0) for 20 min prior to Western blot-
ting with anti-ubiquitin (Tebu Bio, catalog no. VU101) to detect
ubiquitinated p50 species.
Luciferase Assay—RAW 264.7 and Nfkb1/ MEFs were
transiently transfected with the pLucp19 plasmid for 24 h and
cultured with or without 100 ng/ml LPS (Sigma) or 20 ng/ml
TNF (eBiosciences) for an additional 8 h before luciferase
activity was measured. Cotransfection of the Renilla luciferase
expression vector pRL-TK (Promega) was used as an internal
control for all reporter assays. Cells were lysed in 1 passive
lysis buffer (Promega), and, for all samples, firefly luciferase
activity (25 mM glycylglycine, 15 mM potassium K2PO4 (pH 8), 4
mM EDTA, 15 mM magnesium sulfate, 75 M luciferin, 1 mM
dithiothreitol, 0.1 mM coenzyme A, and 2 mM ATP) was divided
by Renilla luciferase activity (1.1 M sodium chloride, 2.2 mM
EDTA, 220 mM K2PO4 (pH 5.1), 0.44 mg/ml bovine serum albu-
min, sodium azide, and 1.43 M coelenterazine) to normalize
for the transfection efficiency, as described previously (21).
EMSA—IR-800 dye-labeled (DY782) NF-B consensus dou-
ble-stranded oligonucleotides (5-AGTTGAGGGGACTTTC-
CCAGGC-3 and 3-TCA ACT CCC CTG AAA GGG TCC
G-5) were purchased from MWG Operon. Binding reactions
were prepared using 5 g of nuclear extract with 10 ng of oli-
gonucleotides in a 30-l reaction volume containing 10 mM
HEPES KOH (pH 7.9), 50 mM KCl, 2.5 mM MgCl2, 1 mM DTT,
10% Ficoll, 1.2 g of bovine serum albumin, and 3.6 g of
poly[d(I-C)] at room temperature for 15 min. Binding reactions
were resolved on a 5% non-denaturing polyacrylamide gel at
300 V and 4 °C in 1 TBE (0.089 M Tris borate, 0.089 M boric
acid, and 0.002 M EDTA). Gels were visualized using LI-COR
odyssey.
Gene Expression Analysis—For real-time PCR, total RNA was
isolated using RNeasy kits (Qiagen), primed with random
hexamer oligonucleotides, and reverse-transcribed using a
cDyNAmo cDNA synthesis kit (Thermo Scientific). PCR was
performed with SensiMix SYBR master mix and Tnf, Il6, Cxcl2,
and Ccl2 QuantiTect primers (Qiagen). Data were normalized
to 18 S. Gene expression changes were calculated using the
2CT method.
RESULTS
Identification of Regions of p50 Required for Interaction with
Bcl-3—The crystal structures of the Bcl-3 and p50 homodimers
have been resolved independently, and computational model-
ing of a Bcl-3p50 homodimer complex indicates that Bcl-3
makes a number of contacts with amino acids in both subunits
of a p50 homodimer (22). To experimentally identify the
regions of p50 mediating interaction with Bcl-3, we immobi-
lized p50 using peptide array-based techniques and probed the
arrays using purified recombinant GST-Bcl-3 protein. Specifi-
cally, a library of overlapping peptides 18 amino acids in length,
each shifted by three amino acids and encompassing the entire
sequence of p50, was SPOT-synthesized on nitrocellulose
membranes to generate p50 arrays. Peptide arrays were over-
laid with purified recombinant GST or GST-Bcl-3 protein and,
following extensive washing, probed with anti-GST antibody as
described previously(23, 24, 25). The suitability of GST-Bcl-3
for use as a p50 peptide library probe was established using a
GST pulldown assay in which purified GST-Bcl-3, but not GST,
bound to p50 (Fig. 1A). The p50 peptide arrays identified a
distinct set of p50 peptides that interacted strongly with GST-
Bcl-3 but not with GST (Fig. 1B). These peptides corresponded
to residues 337–378 of p50 (murine), which contain the
extreme C-terminal region of the RHD of p50.
To identify the specific amino acids within this region of p50
that are crucial for interaction with Bcl-3, we next employed
alanine-scanning arrays containing the amino acid sequence
355–372 of p50 (Fig. 1C). In these arrays, successive amino
acids were individually substituted with alanine, differing from
the parent peptide by one amino acid, and then incubated with
GST-Bcl-3 prior to staining with anti-GST antibody. In each
case, the binding of GST-Bcl-3 to the substituted peptide was
calculated with respect to the parent peptide contained on
the same array. These data demonstrate that alanine substitu-
tions at Arg-359, Lys-360, Arg-361, and Lys-363 significantly
decreased GST-Bcl-3 binding when compared with the parent
p50 peptide (Fig. 1C). The identified residues lie in the extreme
C-terminal region of the RHD of p50 and are not represented in
the structures of p50 currently available. However, a hydropho-
bicity analysis of the primary structure of p50 indicated that
these residues are in a region of low hydrophobicity and, there-
fore, are likely to be available for interaction with Bcl-3 (Fig.
1D).
Arg-359, Lys-360, Arg-361, and Lys-363 of p50 Are Essential
for Interaction with Bcl-3—To evaluate the contribution of res-
idues Arg-359, Lys-360, and Arg-361 of p50 to the interaction
with Bcl-3, we next performed a GST pulldown assay employ-
ing purified GST-Bcl-3 and lysates generated from HEK293T
cells expressing wild-type p50 (p50WT) or p50 in which
Arg-359, Lys-360, and Arg-361 had been mutated to alanine
(p50RKR). As expected, GST-Bcl-3 pulldown readily purified
p50WT. However, p50RKR protein was not detectable following
GST-Bcl-3 pulldown from p50RKR containing lysates (Fig. 2A).
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FIGURE 1. Analysis of p50 and Bcl-3 interaction using peptide arrays. A, p50 binds specifically to GST-Bcl3 in a GST pulldown assay. Purified bacterial
recombinant GST or GST-Bcl-3 was incubated with a whole HEK293 cell lysate overexpressing FLAG-p50 and was affinity-purified with GSH-agarose.
Pulldown complexes were immunoblotted with anti-FLAG and anti-GST antibodies. Full-length GST-Bcl-3 is indicated. WB, Western blot. B, peptide
arrays of immobilized, overlapping 18-mer peptides, each shifted to the right by three amino acids, encompassing the entire p50 sequence were
generated. The arrays were probed with GST or GST-Bcl-3 and detected by immunoblotting with anti-GST antibody. GST-Bcl-3 binding to p50 peptides
is shown and is representative of duplicate arrays. Sequences of peptides are shown, with Bcl-3 interacting peptides indicated in gray. C, the 18 amino
acids of p50-derived peptide 119 were sequentially substituted with alanine, and a peptide array was probed with GST-Bcl-3. Bcl-3 binding was
quantified by densitometry and represented as a percentage of binding of the control parent peptide. Substitution of amino acids Arg-359, Lys-360,
Arg-361 and Lys-363 with alanine (shaded in gray) significantly decreased Bcl-3 binding. D, hydrophobicity analysis of p50, with amino acids 359 –363
indicated in a region of low hydrophobicity.
FIGURE 2. Arg-359, Lys-360, Arg-361, and Lys-363 are essential for interaction with Bcl-3. A, purified bacterial recombinant GST or GST-Bcl3 was incubated
with a whole cell lysate overexpressing FLAG-p50 or p50 in which Arg-359, Lys-360, and Arg-361 were mutated to alanine (p50RKR) and was affinity-purified
with GSH-agarose. Pulldown complexes were analyzed by Western blot (WB) analysis with anti-FLAG and anti-GST antibodies. Full-length GST-Bcl-3 is indi-
cated. B, HEK293T cells were transfected with p50 or p50RKR with or without Myc-Bcl-3. Whole cell lysates were immunoprecipitated (IP) with anti-FLAG
antibody and analyzed by Western blot analysis with the indicated antibodies. C, HEK293T cells were transfected with p50 or p50K363A with Myc-Bcl-3. Whole
cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blot analysis with the indicated antibodies. Bcl-3 is a hyperphosphor-
ylated protein and migrates as multiple bands between 48 – 60 kDa.
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These data confirm our initial findings using peptide microar-
rays and further validate this method for mapping sites of pro-
tein-protein interaction. We further assessed the interaction of
the p50RKR mutant with Bcl-3 by cotransfection in HEK293T
cells. Similar to our findings using GST pulldown assays, we
were unable to detect Bcl-3 in immunoprecipitates of p50RKR,
although Bcl-3 was readily detectable in immunoprecipitates
of p50WT (Fig. 2B). Similarly, the mutation of Lys-363 abolished
the interaction of p50 with Bcl-3 when coexpressed in
HEK293T cells (Fig. 2C).
To rule out an indirect effect of Arg-359, Lys-360 and Arg-
361 mutation on the ability of the p50RKR mutant to interact
with Bcl-3, we performed additional characterization of the
p50RKR mutant protein. Homodimerization of p50RKR was
assessed by cotransfection of HEK293T cells with FLAG-tagged
and Myc-tagged p50RKR or FLAG-tagged and Myc-tagged
p50WT. Lysates were immunoprecipitated using anti-FLAG
antibody and immunoblotted with anti-Myc antibody. This
analysis demonstrated no significant differences in the forma-
tion of homodimers by p50RKR when compared with p50WT
protein (Fig. 3A). We next assessed the heterodimerization of
p50RKR using a similar approach. Myc-tagged p50WT or p50RKR
was coexpressed with FLAG-tagged NF-B p65 and lysates
immunoprecipitated using anti-FLAG antibody. Immunoblot
analysis of FLAG-p65 immunoprecipitates demonstrated no
differences in the levels of p50RKR coimmunoprecipitating with
p65 relative to p50WT, indicating that the p50RKR mutation has
no effect on heterodimerization with p65 (Fig. 3B). IB has a
high affinity for p65/p50 heterodimers. Therefore, we also
assessed the levels of endogenous IB in p65 immunoprecipi-
tates from cells expressing p50WT or p50RKR. No significant
differences in the amount of IB coimmunoprecipitating with
p65 was found between cells expressing p50WT or p50RKR (Fig.
3B). Similarly, we observed no difference in the levels of p50RKR
interacting with p105 relative to p50WT in cells cotransfected
with p105 and p50WT or p50RKR, as assessed by immunopre-
cipitation (Fig. 3C). Together, these data demonstrate that the
p50RKR mutation does not alter p50 dimerization or interaction
with IB or p105 proteins.
Amino acids 359 –361 of p50 have been indicated previously
to function in the nuclear translocation of p50 (26). Because
Bcl-3 is predominantly nuclear in localization, it was important
to rule out the possibility that lack of nuclear p50RKR prevented
the interaction with Bcl-3 in cotransfected cells. To address
this, we generated nuclear and cytoplasmic fractions of
cells transfected with p50RKR or p50WT and analyzed protein
levels by immunoblot analysis. As demonstrated in Fig. 4A, sub-
cellular fractionation revealed that p50RKR translocated to the
nucleus to similar levels as p50WT, indicating that the mutation
of amino acids 359 –361 to alanine does not disrupt the nuclear
localization of p50. These data were supported by an analysis of
the DNA-binding activity of p50RKR using EMSA, which incor-
FIGURE 3. Mutation of Arg-359, Lys-360, and Arg-361 does not affect the
dimerization properties of p50. p50RKR can form homodimers (A) and het-
erodimers with p65 (B) and p105 (C). A and B, HEK293T cells were transfected
as indicated. FLAG-p50 or FLAG-p50RKR (A) and FLAG-p65 (B) were immuno-
precipitated (IP) from whole cell lysates with anti-FLAG antibody and ana-
lyzed by Western blot (WB) analysis with anti c-Myc for Myc -p50 and p50RKR
and anti IB. C, Myc-p50 or p50RKR was immunoprecipitated from whole cell
lysates with anti-c-Myc antibody and analyzed by Western blot analysis with
anti-FLAG antibody for p105.
FIGURE 4. p50RKR can bind DNA and translocate to the nucleus. A, HEK293T
cells were transfected with expression plasmids as indicated. Nuclear extracts
were prepared from the transfected cells and tested in an EMSA using the
consensus NF-B-binding nucleotide. N, nuclear; C, cytoplasmic; WB, Western
blot. B, nuclear and cytoplasmic extracts were prepared from HEK293T cells
transfected with expression plasmids as indicated. p50 and p50RKR subcellu-
lar localization was analyzed by Western blot analysis with anti-FLAG
antibody.
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porated a double-stranded oligonucleotide probe containing
the NF-B consensus DNA-binding sequence and nuclear
extracts from 293T cells transfected with expression vectors for
p50WT or p50RKR. No significant differences were seen in the
DNA-binding activity of p50RKR compared with p50WT (Fig.
4B). Taken together, these data reveal that the p50RKR mutant is
defective in binding to Bcl-3 but retains the p50WT properties of
nuclear translocation, dimerization, and DNA binding.
Arg-359, Lys-360, and Arg-361 of p50 Are Critical for Protein
Stability—Previous studies of Bcl3/ cells suggested that
Bcl-3 regulates NF-B-mediated transcription through inhibi-
tion of p50 homodimer ubiquitination and proteasomal degra-
dation (18). The ubiquitination of p50 is increased significantly
in Bcl3/ cells, and overexpression of Bcl-3 inhibits p50 ubiq-
uitination (18). To establish whether the inhibition of p50 ubiq-
uitination by Bcl-3 requires interaction with p50, we performed
a ubiquitination assay in HEK293T cells transfected with HA-
tagged ubiquitin, p50WT, or p50RKR with or without Bcl-3. Fol-
lowing denaturing lysis, p50 was immunoprecipitated and
immunoblotted with anti-HA antibody. This analysis revealed
significantly increased ubiquitination of p50RKR relative to
p50WT (Fig. 5A). Furthermore, in contrast to the complete inhi-
bition of p50WT ubiquitination by Bcl-3, the expression of Bcl-3
failed to inhibit the ubiquitination of p50RKR (Fig. 5A). Similar
results were obtained when cells were transfected with
p50K363A (Fig. 5B). These data demonstrate that the interaction
of Bcl-3 with p50 is required for Bcl-3-mediated inhibition of
p50 ubiquitination. p50 ubiquitination leads to degradation by
the proteasome and, thereby, controls p50 protein stability. We
next assessed the stability of p50RKR by treating p50WT- or
p50RKR-expressing cells with the protein synthesis inhibitor
cycloheximide and monitoring protein levels over a short time
period by immunoblotting. This analysis demonstrated that
p50RKR is significantly less stable than p50WT and has a half-life
of less than 50% than that of p50WT (Fig. 5C). These data dem-
onstrate that interaction with Bcl-3 is critical for the regulation
of p50 ubiquitination and protein stability.
Arg-359, Lys-360, and Arg-361 of p50 Are Critical for Nega-
tive Regulation of NF-B-dependent Gene Expression—It has
been proposed that Bcl-3 regulates NF-B-mediated transcrip-
tion through inhibition of p50 homodimer ubiquitination and
proteasomal degradation (18). However, additional p50-inde-
pendent functions of Bcl-3 in regulating transcription cannot
be ruled out in studies employing Bcl3/ cells. Our finding
that the interaction of p50 with Bcl-3 is important for regulat-
ing the stability of ubiquitination and the stability of p50 led us
to examine the regulation of gene transcription by p50RKR. To
investigate this, we first employed a luciferase reporter assay
incorporating the NF-B-dependent IL-23p19 gene promoter
(27). In agreement with previous reports (28), Bcl-3 expression
inhibited the reporter activity in RAW 264.7 macrophage cells
following stimulation with LPS. Similarly, overexpression of
both p50WT and p50RKR inhibited LPS-induced reporter activ-
ity. However, although coexpression of p50WT with Bcl-3 com-
pletely abolished LPS-induced reporter activity, the coexpres-
sion of p50RKR with Bcl-3 failed to inhibit reporter activity
below the level seen when either protein is expressed alone (Fig.
6A). Next, we performed a dose-dependent analysis of p50WT
and p50RKR expression on IL-23p19 reporter activity by trans-
fecting increasing but low amounts of the p50WT or p50RKR
expression vector in Nfkb1/ MEFs. Here we observed a dose-
dependent inhibition of reporter activity following transfection
with p50WT but not with p50RKR (Fig. 6B). Similar results were
obtained when Nfkb1/ MEFs were transfected with an
expression vector for wild-type p105 (p105WT) or p105 con-
taining alanine substitutions at positions 359 –361 (p105RKR)
(Fig. 6C). Together, these data demonstrate that the interaction
FIGURE 5. Arg-359, Lys-360, and Arg-361 of p50 are critical for protein stability. A, Bcl-3 cannot block p50RKR ubiquitination. HEK293T cells were transfected
as indicated. p50 ubiquitination was determined by immunoprecipitation (IP) from whole cell lysates with anti-FLAG antibody and Western blotting (WB) with
anti-HA antibody for HA-ubiquitin (Ub). B, Bcl-3 cannot block p50K363A ubiquitination. HEK293T cells were transfected as indicated. p50 ubiquitination was
determined by immunoprecipitation from whole cell lysates with anti-FLAG antibody and Western blotting with anti-HA antibody for HA-ubiquitin. C, reduced
half-life of p50RKR. HEK293T cells were transfected with FLAG-p50 or p50RKR. Following transfection, cells were treated with 100 g/ml cycloheximide (CHX) and
harvested at the indicated times. For each sample, p50 protein levels were quantified by densitometry and normalized with -actin. The half-life of p50 and
p50RKR was calculated from three independent experiments and is presented as mean  S.D.
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between Bcl-3 and p50 is critical for the negative regulation of
NF-B target genes by both of these factors.
p105RKR Expression Recapitulates the Bcl3/ Phenotype—
To further analyze the lack of p50Bcl-3 complex formation in
the context of an inflammatory signal, we next reconstituted
Nfkb1/ MEFs with expression vectors for p105WT or
p105RKR. Stably transfected cells were clonally selected for
equivalent expression of p105WT and p105RKR (Fig. 7A). We
found no differences in the activation of the NF-B pathway by
TNF between p105WT and p105RKR cells, as determined by
IB phosphorylation and degradation (Fig. 7B). TNF-in-
duced nuclear localization of p50 and p65 was not altered sig-
nificantly in p105RKR cells relative to p105 WT cells. However,
p105RKR cells had significantly reduced p50 protein levels com-
pared with p105WT cells (Fig. 7C), reflecting the reduced stabil-
ity of p50RKR (Fig. 5C). In agreement with an overexpression
analysis (Fig. 2), endogenous Bcl-3 failed to coimmunoprecipi-
tate with p50 RKR in TNF-stimulated cells, whereas TNF-in-
ducible interaction with wild-type p50 was readily detectable
(Fig. 8A). Consequently, endogenous ubiquitination of p50RKR
in both untreated and TNF-stimulated cells was elevated rel-
ative to p50WT (Fig. 8B). Real-time PCR analysis of TNF-in-
duced gene expression revealed that p105RKR cells express sig-
nificantly higher levels of the NF-B target genes TNF, IL-6,
CCL2, and CXCL2 when compared with p105WT cells (Fig. 8C).
This hyperresponsiveness toward TNF stimulation in
p105RKR cells correlates with the increased ubiquitination
and reduced half-life of the p50RKR protein and, importantly,
recapitulates the hyperresponsiveness of Bcl3/ cells (18).
Together, these data demonstrate that interaction with Bcl-3 is
essential for p50 homodimer repressor function and suggest
that repression of transcription by Bcl-3 is dependent on inter-
action with p50 homodimers.
FIGURE 6. Arg-359, Lys-360, and Arg-361 of p50 are critical for negative
regulation of NF-B-dependent gene expression. A, Bcl-3 is unable to syn-
ergize with p50RKR to inhibit LPS-induced activation of IL23 p19 reporter
activity. RAW 264.7 cells were transiently transfected with the pLucp19 plas-
mid and with an empty expression vector or expression vectors containing
p50 or p50RKR and Bcl-3 for 24 h and cultured with or without 100 ng/ml LPS
for an additional 8 h before luciferase activity was measured. The Renilla lucif-
erase expression vector pRLTK was used as an internal control to normalize
the transfection efficiency across all samples. Reporter activity is represented
as fold increase over untreated (UNT) cells transfected with the pLucp19 plas-
mid and empty vector expression. B and C, Nfkb1/ MEFs were transiently
transfected with the pLucp19 plasmid and increasing amounts of expression
vectors containing p50 or p50RKR (B) or p105 or p105RKR (C). The total amount
of plasmid was kept constant across all samples by adjusting the amount of
empty vector used. Cells were transfected for 24 h and cultured with or with-
out 20 ng/ml TNF for an additional 8 h before luciferase activity was mea-
sured. Transfection efficiency was normalized with pRLTK as in A. Data are
mean  S.E. of triplicate samples and are representative of three independent
experiments. Statistical significance between corresponding WT and RKR
mutant reporter activities was determined by Student’s t test. *, p  0.01; **,
p  0.005; ***, p  0.0001.
FIGURE 7. Normal upstream signaling and NF-B nuclear translocation
of p105RKR MEFs. A, Nfkb1/MEF cells were stably transfected with
expression vectors encoding p105WT or p105RKR. B, p105WT or p105RKR
MEFs were stimulated with 20 ng/ml TNF for the indicated times prior to
lysis. Whole cell extracts were analyzed by Western blotting for phosphor-
ylated IB and total IB. C, p105WT or p105RKR MEFs were stimulated
with 20 ng/ml TNF for the indicated times prior to lysis. Nuclear and
cytoplasmic extracts were prepared and analyzed for p50 and p65 pro-
teins by Western blot analysis.
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Bcl-3 is an IB protein that regulates NF-B-dependent gene
expression through interaction with NF-B p50 and p52
homodimers (18). In addition to the NF-B subunits, Bcl-3
interacts with a number of regulators of transcription, includ-
ing c-Jun and c-fos (8); STAT1 (9); PPAR (10); CREB-binding
protein/p300 (8); HDAC-1, -3, and -5 (11); steroid receptor
coactivator 1(8); TORC3 (12); and retinoic X receptor (13); Fyn
(14) and Lck (15); insulin receptor substrate 3 (IRS3) (16); and
Bag-1 (17). The contribution of these factors to immune regu-
lation by Bcl-3 has not been determined previously. Bcl-3 limits
NF-B-mediated transcription of proinflammatory cytokines
and promote LPS tolerance, a state of hyporesponsiveness fol-
lowing repeated or prolonged exposure to LPS (18). Previous
studies have demonstrated that Bcl-3 regulates p50 homodimer
stability through the inhibition of ubiquitination and subse-
quent proteasomal-mediated degradation (18). However, stud-
ies employing Bcl3/ cells and mice do not exclude the possi-
bility that Bcl-3 may also function through p50-independent
mechanisms to regulate gene expression. Here, by identifying
the critical site of p50 necessary for interaction with Bcl-3, we
provide the first direct evidence that Bcl-3-mediated repression
of NF-B-mediated gene expression requires interaction with
p50. Furthermore, our data demonstrate that p50 that cannot
interact with Bcl-3 is inherently unstable and undergoes
increased ubiquitination and degradation relative to wild-type
p50, even in the presence of overexpressed Bcl-3. Our data also
suggest that p50-independent targets of Bcl-3 are not impor-
tant in the regulation of NF-B-dependent inflammatory gene
expression.
In this study, we employed peptide array techniques to iden-
tify residues of p50 necessary for interaction with Bcl-3. This
approach, which uses immobilized peptides representing the
p50 protein sequence, has distinct advantages over deletional
mutagenic approaches. Perhaps chief among these is the avoid-
ance of potential artifacts on the formation of multisubunit
complexes, which may result from the deletion of significant
portions of a protein. For example, the RHD of p50 is essential
for dimerization as well as DNA binding. Even partial deletion
of the RHD may have consequences on the formation of a Bcl-
3p50 complex. In this study, the immobilized peptide array
approach allowed us to identify a series of overlapping peptides
with a strong affinity for purified recombinant Bcl-3 corre-
sponding to amino acids 337–378 at the C-terminal region of
p50. The serial substitution of amino acids 355–372 with ala-
nine as immobilized peptide arrays further increased the reso-
lution of the site and identified Arg-359, Lys-360, Arg-361 and
Lys-363 as essential residues for interaction with Bcl-3. Subse-
quently, the mutation of Arg-359, Lys-360, and Arg-361 to ala-
nine in full-length p50 blocked the interaction with purified,
recombinant Bcl-3. These data validate peptide array technol-
ogy as a valuable tool in identifying sites of protein-protein
interaction with amino acid level resolution.
The region of p50 containing Arg-359, Lys-360, and Arg-361
is C-terminal to previously identified ankyrin repeat domain
interaction sites determined from the crystal structure of a p65/
p50 heterodimer complexed with IB. Unfortunately, amino
acids 359 –361 are not represented on the crystal structures of
p50-containing complexes, and, therefore, no structural data
are available. However, a hydrophobicity plot reveals that these
amino acids lie in a region of low hydrophobicity and, thus, are
expected to be available for interaction with Bcl-3. Importantly,
mutation of these amino acids does not alter the hetero- or
homodimer formation properties of p50 or interfere with DNA
binding of p50. This allows us to rule out the loss of repressor
function of p50RKR homodimers because of a lack of dimeriza-
tion or DNA binding. Moreover, despite being located in a
region reported previously to be important for nuclear localiza-
tion (26), the mutation of Arg-359, Lys-360, and Arg-361 to
alanine had no effect on the nuclear localization of p50, as mon-
itored by subcellular fractionation analysis and DNA binding
assays. Our data suggest that additional sequences of p50 are
important in its nuclear translocation.
FIGURE 8. p105RKR MEFs are hyperresponsive to TNF stimulation. A, p105WT or p105RKR MEFs were left untreated () or stimulated with 10 ng/ml TNF ()
for 1 h. Cells were pretreated with MG132 for 30 min prior to harvest. p50WT and p50RKR were immunoprecipitated (IP) from whole cell lysates and analyzed by
Western blot analysis with anti-Bcl-3 antibody for endogenous Bcl-3. B, endogenous ubiquitination assay. p105WT or p105RKR MEFs were treated as in A. p50WT
and p50RKR were immunoprecipitated from whole cell lysates, and ubiquitination was determined by Western blot analysis with anti-ubiquitin (Ub). C, p105WT
or p105RKR MEFs were stimulated with 20 ng/ml TNF. Gene expression levels were determined by real-time PCR. Data are mean  S.E. of triplicate samples and
are representative of three independent experiments.
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The mutation of Arg-359, Lys-360, and Arg-361 in p50
(p50RKR) functionally recapitulates the phenotype of Bcl3/
cells described previously. Thus, p50RKR undergoes increased
ubiquitination corresponding to a reduced half-life, and cells
expressing p50RKR display increased NF-B transcriptional
activity relative to wild-type p50. Critically, Bcl-3 is unable to
rescue the increased NF-B activity in p50RKR-expressing cells.
NF-B transactivation is not inhibited by overexpression of
Bcl-3 in cells expressing p50RKR, and Bcl-3 is unable to inhibit
p50RKR ubiquitination. The importance of p50 in regulating
transcriptional programs during inflammation has been high-
lighted by two recent studies of Toll-like receptor- (29) and
interferon-induced responses (5). Our study further highlights
the importance of Bcl-3 and p50 interaction in the regulation of
the inflammatory response independently of the interaction of
Bcl-3 with other transcriptional regulators.
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